These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 23678554)

  • 21. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnosis and management of hereditary angioedema in a Greek family.
    Papadopoulou-Alataki E; Foerster T; Antari V; Pavlitou-Tsiontsi A; Varlamis G
    Int Arch Allergy Immunol; 2008; 147(2):166-70. PubMed ID: 18535392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
    Wu MA; Zanichelli A; Mansi M; Cicardi M
    Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress with management of hereditary angioedema].
    Johnston DT; Lode H
    MMW Fortschr Med; 2013 Mar; 155 Suppl 1():1-5. PubMed ID: 23678665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenesis of hereditary angioedema].
    Reimold WV
    Z Gastroenterol; 1987 Jun; 25(6):316-24. PubMed ID: 3617844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five novel mutations in the C1 inhibitor gene (C1NH) leading to a premature stop codon in patients with type I hereditary angioedema.
    Freiberger T; Kolárová L; Mejstrík P; Vyskocilová M; Kuklínek P; Litzman J
    Hum Mutat; 2002 Apr; 19(4):461. PubMed ID: 11933207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quincke's edema: diagnosis and management of 102 patients with sudden upper airway obstruction].
    Stelter K; Lübbers CW; Andratschke M; Leunig A
    Laryngorhinootologie; 2007 Jun; 86(6):416-9. PubMed ID: 17487816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
    Bernstein JA
    Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I hereditary angioedema in Taiwan -- clinical, biological features and genetic study.
    Lei WT; Shyur SD; Huang LH; Kao YH; Lo CY
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):327-31. PubMed ID: 22299312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic test indications and interpretations in patients with hereditary angioedema.
    Weiler CR; van Dellen RG
    Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.
    Farkas H; Martinez-Saguer I; Bork K; Bowen T; Craig T; Frank M; Germenis AE; Grumach AS; Luczay A; Varga L; Zanichelli A;
    Allergy; 2017 Feb; 72(2):300-313. PubMed ID: 27503784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency.
    Zotter Z; Nagy Z; Patócs A; Csuka D; Veszeli N; Kőhalmi KV; Farkas H
    Orphanet J Rare Dis; 2017 Jan; 12(1):5. PubMed ID: 28069032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the diagnosis and management of hereditary angioedema with abnormal C1 inhibitor.
    Davis-Lorton M
    J Drugs Dermatol; 2015 Feb; 14(2):151-7. PubMed ID: 25689810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
    Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
    Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1-inhibitor deficiency and angioedema.
    Carugati A; Pappalardo E; Zingale LC; Cicardi M
    Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.